Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432674 · ClinicalTrials.gov registry record · Phase 1
Digital Fall Prevention Study
A Phase 1 study of Fall, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05432674: Completed Phase 1 study of Fall, sponsored by Brigham and Women's Hospital.
NCT05432674 is a Phase 1 study of Fall that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 23 participants, below the 1,307-participant average among 19 other Fall trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432674, a Phase 1 study of Fall, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The Digital Fall Prevention Study is a single-group unblinded study to explore the feasibility and acceptability of a 3-month fall prevention exercise program delivered digitally via a tablet interface. Evidence-based exercise programs and motivational techniques will be used along with new wearable technology to predict fall risk.
Primary Outcome
Percentage of scheduled exercise sessions complete (70% of sessions completed = acceptable adherence)
Conditions Studied
Interventions
- COMBINATION_PRODUCT Digital Fall Prevention
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-06-30 |
| Est. Completion | 2023-06-01 |
| Phase | Phase 1 |
What the finished NCT05432674 record still lists
NCT05432674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,307-participant average among 19 other Fall trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Fall appearing as the primary indexed condition, and to 1 intervention - of which Digital Fall Prevention is the first listed.
NCT05432674 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05432674 about?
NCT05432674 is a clinical study titled "Digital Fall Prevention Study". The Digital Fall Prevention Study is a single-group unblinded study to explore the feasibility and acceptability of a 3-month fall prevention exercise program delivered digitally via a tablet interface. Evidence-based exercise programs and motivational techniques will be used along with new wearable...
What is the current status of trial NCT05432674?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2022-06-30. Estimated completion is 2023-06-01.
What conditions does trial NCT05432674 study?
This clinical trial studies the following conditions: Fall.
What interventions are being tested in trial NCT05432674?
The interventions under investigation include: Digital Fall Prevention (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05432674?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432674 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fall
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05432674's enrollment target sits among peer trials
23 18th of 19 higher than 2 of 19 other Fall trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Optimizing a Technology-based Body and Mind Intervention
RECRUITING · NA
-
Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults
RECRUITING · NA
-
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
RECRUITING · NA
-
Real-life Dual-Task Training
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI